Clarity in every comparison.What is Mounjaro?
Mounjaro contains tirzepatide, which acts on GIP and GLP-1 receptors. Its Canadian product information concerns type 2 diabetes. Lilly announced an indication extension to patients aged 10–17 on July 7, 2026.
Mounjaro and Zepbound: same ingredient, different products
Mounjaro and Zepbound share tirzepatide but carry separate product authorizations. A price comparison is not a recommendation to switch brands or use a product outside its authorized indication.
What changed in Mounjaro’s Canadian authorization?
The July 2026 pediatric announcement concerns blood-sugar control in type 2 diabetes, not pediatric weight-management approval.
Read the update →Before you fill your prescription
A vial quote and a KwikPen quote may describe different quantities. Ask for the exact presentation, concentration and package size before comparing costs.
Ask your pharmacy for a quote showing the exact DIN, package, days supplied, dispensing fee and delivery. If you use an online provider, check visit and membership charges separately.
For insurance, confirm the exact DIN, any prior authorization and your remaining deductible or limits with your plan.
Check coverage steps →Product sources and review details
Sources reviewed 2026-09-20. Check the current Canadian product information with your pharmacist for dosing and safety questions.
Mounjaro product source